Subsequently, mice received either the BCL-XL inhibitor (25 mg/kg, daily by oral gavage), 5FU (30 mg/kg, 3× per week by i.p. injection), the combination of both or solely the respective solvents as a control for 2 weeks, and afterwards tumor numbers and diameters were determined. Here, BCL2L1 is linked to neoplasm.